See more : SEM Holdings Limited (9929.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Avinger, Inc. (AVGR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avinger, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Empire Company Limited (EMP-A.TO) Income Statement Analysis – Financial Results
- CPT Global Limited (CGO.AX) Income Statement Analysis – Financial Results
- GD Power Development Co.,Ltd (600795.SS) Income Statement Analysis – Financial Results
- Groupe Airwell Société anonyme (MLAIR.PA) Income Statement Analysis – Financial Results
- Filtra Consultants and Engineers Limited (FILTRA.BO) Income Statement Analysis – Financial Results
Avinger, Inc. (AVGR)
About Avinger, Inc.
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.65M | 8.27M | 10.13M | 8.76M | 9.13M | 7.92M | 9.93M | 19.21M | 10.71M | 11.21M | 12.96M | 8.56M |
Cost of Revenue | 5.65M | 5.62M | 6.71M | 6.14M | 6.26M | 6.53M | 13.00M | 14.45M | 6.48M | 6.51M | 8.21M | 4.15M |
Gross Profit | 2.00M | 2.65M | 3.42M | 2.62M | 2.87M | 1.38M | -3.07M | 4.77M | 4.24M | 4.70M | 4.76M | 4.41M |
Gross Profit Ratio | 26.18% | 32.08% | 33.80% | 29.88% | 31.40% | 17.49% | -30.88% | 24.82% | 39.53% | 41.92% | 36.71% | 51.51% |
Research & Development | 4.54M | 4.39M | 5.90M | 5.70M | 5.69M | 6.01M | 11.32M | 15.54M | 15.69M | 11.22M | 15.97M | 15.42M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.44M | 25.12M | 39.95M | 29.23M | 18.50M | 25.76M | 22.85M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 515.00K | 720.00K | 321.00K | 732.00K |
SG&A | 14.10M | 14.22M | 15.63M | 14.33M | 16.53M | 17.44M | 25.12M | 39.95M | 29.23M | 18.50M | 25.76M | 22.85M |
Other Expenses | 0.00 | -1.00K | 2.34M | 56.00K | 1.10M | -13.00K | 11.00K | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 18.64M | 18.61M | 21.53M | 20.02M | 22.23M | 23.45M | 36.44M | 55.49M | 44.93M | 29.73M | 41.73M | 38.26M |
Cost & Expenses | 24.29M | 24.23M | 28.23M | 26.17M | 28.49M | 29.98M | 49.44M | 69.93M | 51.40M | 36.24M | 49.94M | 42.42M |
Interest Income | 0.00 | 1.67M | 3.00K | 34.00K | 288.00K | 214.00K | 108.00K | 125.00K | 40.00K | 2.00K | 11.00K | 25.00K |
Interest Expense | 1.72M | 1.67M | 1.65M | 1.66M | 1.48M | 5.48M | 6.30M | 5.52M | 5.17M | 6.02M | 2.93M | 6.00K |
Depreciation & Amortization | 289.00K | 1.30M | 1.69M | 1.86M | 1.57M | 1.28M | 1.48M | 1.51M | 1.30M | 1.45M | 1.50M | 772.00K |
EBITDA | -16.35M | -15.76M | -17.41M | -16.42M | -16.40M | -20.59M | -40.96M | -49.10M | -40.88M | -24.48M | -35.46M | -33.08M |
EBITDA Ratio | -213.62% | -192.89% | -155.62% | -198.01% | -212.01% | -278.96% | -396.61% | -263.31% | -379.45% | -223.18% | -273.53% | -386.19% |
Operating Income | -16.64M | -15.96M | -18.10M | -17.40M | -19.36M | -22.07M | -42.55M | -50.72M | -40.69M | -25.03M | -36.97M | -33.86M |
Operating Income Ratio | -217.39% | -192.88% | -178.69% | -198.65% | -212.01% | -278.80% | -428.35% | -263.96% | -379.82% | -223.20% | -285.19% | -395.50% |
Total Other Income/Expenses | -1.69M | -1.67M | 689.00K | -1.60M | -91.00K | -5.49M | -6.18M | -5.41M | -6.65M | -6.92M | -2.92M | 0.00 |
Income Before Tax | -18.32M | -17.62M | -17.41M | -19.01M | -19.45M | -27.56M | -48.73M | -56.13M | -47.34M | -31.95M | -39.89M | -33.86M |
Income Before Tax Ratio | -239.41% | -213.02% | -171.89% | -216.94% | -213.01% | -348.17% | -490.56% | -292.12% | -441.93% | -284.94% | -307.70% | -395.50% |
Income Tax Expense | 0.00 | -196.00K | 3.30M | 817.00K | 302.00K | 201.00K | 4.82M | 4.02M | 2.38M | 14.00K | 11.00K | 9.00K |
Net Income | -18.32M | -17.43M | -20.71M | -19.82M | -19.75M | -27.56M | -48.73M | -56.13M | -47.34M | -31.96M | -39.90M | -33.86M |
Net Income Ratio | -239.41% | -210.65% | -204.44% | -226.26% | -216.32% | -348.17% | -490.56% | -292.12% | -441.93% | -285.06% | -307.78% | -395.61% |
EPS | -23.31 | -41.83 | -65.79 | -120.80 | -818.60 | -7.74K | -175.93K | -283.47K | -450.90K | -389.80K | -486.60K | -412.98K |
EPS Diluted | -23.31 | -41.83 | -65.79 | -120.80 | -818.60 | -7.74K | -175.93K | -283.47K | -450.90K | -389.80K | -486.60K | -412.98K |
Weighted Avg Shares Out | 786.00K | 416.60K | 314.80K | 164.10K | 24.13K | 3.56K | 277.00 | 198.00 | 105.00 | 82.00 | 82.00 | 82.00 |
Weighted Avg Shares Out (Dil) | 786.00K | 416.60K | 314.80K | 164.10K | 24.13K | 3.56K | 277.00 | 198.00 | 105.00 | 82.00 | 82.00 | 82.00 |
![News image](https://images.financialmodelingprep.com/news/avinger-to-announce-fourth-quarter-full-year-2020-results-20210302.jpg)
Avinger to Announce Fourth Quarter Full Year 2020 Results on March 11, 2021
![News image](https://images.financialmodelingprep.com/news/avgr-stock-the-social-media-buzz-that-has-avinger-20210218.jpg)
AVGR Stock: The Social Media Buzz That Has Avinger Shares Soaring
![News image](https://images.financialmodelingprep.com/news/avgr-stock-price-increases-over-60-premarket-why-it-20210218.jpg)
AVGR Stock Price Increases Over 60% Pre-Market: Why It Happened
![News image](https://images.financialmodelingprep.com/news/avinger-expands-intellectual-property-portfolio-20210119.jpg)
Avinger Expands Intellectual Property Portfolio
![News image](https://images.financialmodelingprep.com/news/avgr-stock-price-increased-3243-why-it-happened-20210116.jpeg)
AVGR Stock Price Increased 32.43%: Why It Happened
![News image](https://images.financialmodelingprep.com/news/avgr-stock-11-things-to-know-about-avinger-as-20210115.jpg)
AVGR Stock: 11 Things to Know About Avinger as Shares Rocket Higher
![News image](https://images.financialmodelingprep.com/news/avinger-initiates-full-commercial-launch-of-tigereyetm-imageguided-cto-20210115.jpg)
Avinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter
![News image](https://images.financialmodelingprep.com/news/avgr-stock-6-things-to-know-about-robinhoods-hot-20210108.jpg)
AVGR Stock: 6 Things to Know About ‘Robinhood's Hot Penny Stock to Buy' Avinger
![News image](https://images.financialmodelingprep.com/news/avinger-to-participate-in-hc-wainwright-conference-20210106.jpg)
Avinger to Participate in HC Wainwright Conference
![News image](https://images.financialmodelingprep.com/news/avgr-stock-price-increased-6548-this-month-why-it-20201225.jpg)
AVGR Stock Price Increased 65.48% This Month: Why It Happened
Source: https://incomestatements.info
Category: Stock Reports